基本信息
浏览量:3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Petros Grivas is an oncologist with expertise in treating genitourinary cancers such as bladder cancer, prostate cancer and testicular cancer. His clinical research helped lead to FDA approval of new drugs to treat the most common type of bladder cancer. Dr. Grivas currently leads clinical trials that investigate the use of checkpoint inhibitors. These immunotherapy drugs release the brakes on a patient’s immune system and help it mount a better response to cancer.
研究兴趣
论文共 512 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Andrea Necchi,Mathieu Roumiguié,Ashish M Kamat,Neal D Shore,Joost L Boormans,Ahmet Adil Esen,Thierry Lebret,Shuya Kandori,Dean F Bajorin, Laurence E M Krieger, Scot A Niglio, Edward M Uchio,
The Lancet Oncology (2024)
Frederick Okoye,Adam J. Gadzinski,Rishi Sekar,Isabelle Abarro,Petros Grivas, Scott Tykodi, Jay Liao,Jonathan Chen,Jing Zeng,Jonathan Wright,John L. Gore
Clinical Genitourinary Cancerno. 3 (2024): 102058-102058
JCO Precision Oncology (2024)
EUROPEAN UROLOGYno. 3 (2024): 229-238
Petros Grivas,Elena Garralda,Funda Meric-Bernstam,Ingo K Mellinghoff,Lipika Goyal,James J Harding,E Claire Dees,Rastislav Bahleda,Nilofer S Azad,Asha Karippot, Razelle Kurzrock, Josep Tabernero,
Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jean Hoffman-Censits,Petros Grivas, Thomas Powles,Jessica Hawley, Karin Tyroller, Sonja Seeberger,Silke Guenther, Natalia Jacob,Keyvan Tadjalli Mehr,Noah M. Hahn
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn